4-Aminopyridine is a promising treatment option for patients with gain-of-function KCNA2-encephalopathy.
Sci Transl Med. 2021 Sep;13(609):eaaz4957. doi: 10.1126/scitranslmed.aaz4957. Epub 2021 Sep 1.
Sci Transl Med. 2021.
PMID: 34516822